ArticleClinical epigenetics2021

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer.

Braydon Meyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.